"Semustine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
4-Methyl derivative of LOMUSTINE; (CCNU). An antineoplastic agent which functions as an alkylating agent.
MeSH Number(s)
D02.654.692.440.700
D02.948.594.440.700
Concept/Terms
Semustine- Semustine
- MeCCNU
- Methyl-CCNU
- Methyl CCNU
- Me-CCNU
- Me CCNU
Below are MeSH descriptors whose meaning is more general than "Semustine".
Below are MeSH descriptors whose meaning is more specific than "Semustine".
This graph shows the total number of publications written about "Semustine" by people in Harvard Catalyst Profiles by year, and whether "Semustine" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 2 | 2 |
| 1998 | 0 | 1 | 1 |
Below are the most recent publications written about "Semustine" by people in Profiles.
-
FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer. J Exp Med. 2005 Oct 03; 202(7):967-74.
-
PALA versus streptozotocin, doxorubicin, and MeCCNU in the treatment of patients with advanced pancreatic carcinoma. Invest New Drugs. 1998-1999; 16(4):315-8.
-
The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J Clin Oncol. 1994 Dec; 12(12):2640-7.
-
Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med. 1994 Aug 25; 331(8):502-7.
-
The effects of liver directed radiotherapy and chemotherapy on liver function tests and hematological parameters in patients with surgically resected colon cancer: findings from the Gastrointestinal Tumor Study Group. Am J Gastroenterol. 1987 Aug; 82(8):738-43.
-
Adjuvant therapy in rectal cancer: a protocol proposal. Semin Oncol. 1985 Sep; 12(3 Suppl 4):116-20.
-
Intensive induction chemotherapy for small cell anaplastic carcinoma of the lung. Cancer Treat Rep. 1985 Jun; 69(6):571-5.
-
Combination chemo-radiotherapy for residual, recurrent or inoperable carcinoma of the rectum: E.C.O.G. study (EST 3276). Int J Radiat Oncol Biol Phys. 1985 Apr; 11(4):765-71.
-
Radiation therapy alone or in combination with chemotherapy in the treatment of residual or inoperable carcinoma of the rectum and rectosigmoid or pelvic recurrence following colorectal surgery. Radiation Therapy Oncology Group study (76-16). Am J Clin Oncol. 1985 Apr; 8(2):118-27.
-
Urinary tract toxic effects of cancer therapy. J Urol. 1984 Jul; 132(1):1-6.